Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation.

@article{Weisdorf1992SurvivalAR,
  title={Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation.},
  author={Daniel J. Weisdorf and Janet W. Andersen and John H. Glick and Martin M. Oken},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1992},
  volume={10 6},
  pages={942-7}
}
PURPOSE Despite modern therapy, patients with low-grade non-Hodgkin's lymphomas (NHLs) have a median survival of only 7 to 10 years. To determine factors that predict for short survival after relapse and thus to identify candidates for intensive investigational studies including bone marrow transplantation, we have analyzed the combined results of three Eastern Cooperative Oncology Group (ECOG) trials of initial chemotherapy for lymphoma. PATIENTS AND METHODS All 466 patients who achieved… CONTINUE READING